SavedAdd your journal

Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 4

Evaluation of the Relationship Between Rosacea Cutaneous Subtype and Meibography Findings

Funda KEMERİZ
Gülhan Aksoy SARAÇ
Emel ÇALIKOĞLU
Uğur GÜRLEVİK
Erdoğan YAŞAR
Pages
382–386
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The rate of MGLR and MGLG was significantly greater in the AR group than in the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acne rosacea (AR) is a chronic inflammatory skin disease that can cause serious ocular complications.
📊
Key Findings & Data:Materials and Methods: This study included 67 participants with AR and 50 healthy individuals.
💡
Conclusion & Impact:The rate of MGLR and MGLG was significantly greater in the AR group than in the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Acne rosacea (AR) is a chronic inflammatory skin disease that can cause serious ocular complications. This study was designed to evaluate dry eye disease (DED) and meibomian gland dysfunction (MGD) in AR patients and to investigate the relationship between the cutaneous subtype of AR and ocular involvement. Materials and Methods: This study included 67 participants with AR and 50 healthy individuals. Patients diagnosed with 3 cutaneous subtypes were examined: erythematotelangiectatic rosacea (ETR), papulopustular rosacea (PPR), and phymatous rosacea (PR). An ophthalmatological examination was performed that included an evaluation of lid margin alterations due to meibomian gland (MG) obstruction, Ocular Surface Disease Index assessment, tear film break-up time testing, Schirmer testing, and a corneal conjunctival fluorescein staining assessment. Meibography was used to evaluate the upper and lower lids for MG loss. Results: Findings in the AR group revealed MGD in 45.5% and DED in 28.1%. The meibomian gland loss rate (MGLR) was 38.7±16.9% and the meibomian gland loss grade (MGLG) was 1.57±0.82%. The rate of MGLR and MGLG was significantly greater in the AR group than in the control group (p

🔖

Cite This Article

KEMERİZ, F., SARAÇ, G. A., ÇALIKOĞLU, E., GÜRLEVİK, U., YAŞAR, E. (2022). Evaluation of the Relationship Between Rosacea Cutaneous Subtype and Meibography Findings. Erciyes Medical Journal, Cilt: 44 - Sayı: 4, 382–386. https://ajindex.com/articles/502142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51(3): 327–44
  2. Redd TK, Seitzman GD. Ocular rosacea. Curr Opin Ophthalmol 2020; 31(6): 503–7
  3. Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018; 78(1): 148–55
  4. Ozek D, Evren Kemer Ö, Artüz F. Assessment of tear functions in patients with acne rosacea without Meibomian gland dysfunction. Ocul Immunol Inflamm 2019; 27(4): 632–5
  5. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 2011; 52(4): 1930–7
  6. Amano S, Inoue K. Clinic-based study on Meibomian Gland Dysfunction in Japan. Invest Ophthalmol Vis Sci 2017; 58(2): 1283–7
  7. Viso E, Rodríguez-Ares MT, Abelenda D, Oubiña B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 2012; 53(6): 2601–6
  8. Siak JJ, Tong L, Wong WL, Cajucom-Uy H, Rosman M, Saw SM, et al. Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea 2012; 31(11): 1223–8
  9. Palamar M, Degirmenci C, Ertam I, Yagci A. Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea. Cornea 2015; 34(5): 497–9
  10. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46(4): 584–7
  11. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008; 115(5): 911–5
  12. Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf 2017; 15(3): 539–74
  13. Buddenkotte J, Steinhoff M. Recent advances in understanding and managing rosacea. F1000Res. 2018 Dec 3; 7: F1000 Faculty Rev- 1885
  14. Dhingra D, Malhotra C, Jain AK. Ocular Rosacea-A Review. US Ophthalmic Review 2017; 10(2): 113–8
  15. Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: c